Optimized lipid nanoparticles for pulmonary delivery of CRISPR/Cas9 targeting KRAS G12S in lung cancer.
Marschhofer M, Chen S, Molbay M, Winkeljann B, Villano E, Giancaspro C, Kourou A, Berninghausen O, Rieder S, Ungewickell C, Beckmann R, Popper B, Torres AM, Vidal A, Merkel OM, Carneiro SP.
Marschhofer M, et al. Among authors: rieder s.
J Control Release. 2026 Mar 10;391:114607. doi: 10.1016/j.jconrel.2026.114607. Epub 2026 Jan 6.
J Control Release. 2026.
PMID: 41506374
Free article.